Is medical management useful in Moyamoya disease?

Table 2 Delineation of antihypertensive strategies in Moyamoya disease

Antihypertensive treatment	The rationale of treatment in Moyamoya disease
Nicardipine 5-15 mg/h; Labetalol 10 mg IV over 1-2 min followed by infusion of 2-8 mg/min	The early stage of intracerebral hemorrhage
Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Calcium channel blockers (highly lipophilic); Diuretics	Presenting concurrent hypertension: primary and secondary prevention for cerebral ischemia or hemorrhage